Ready To Launch But Nowhere To Go: Regeneron's Eylea Gets FDA Delay
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech says it is prepared to launch the wet-AMD drug immediately following FDA approval, which is now expected by Nov. 18.